A recent study indicates that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a major health publication shows that while obese people can lose about a fifth of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing these drugs must be aware of the risk of rapid weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.
This pace of recovery implies a reversion to starting weight within about 18 months.
Analyzing Treatments
The analysis, which examined dozens of studies involving over 9,000 of patients, compared the results of these new drugs with older methods.
Researchers emphasize that individuals who lose weight through dieting typically have a less rapid weight regain—around 0.1 kg a month—after stopping.
Explaining the Quick Rebound
Experts suggest the mode of action of the injections accounts for the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than the body's typical production could lead to the body to produce less of its endogenous hormone, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement means appetite is unsuppressed, making overeating much more probable."
An Ongoing Condition?
Health authorities suggest the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals argue that, given the significant potential of relapse, the therapy is often ongoing.
This view is echoed by pharmaceutical companies, who say that the findings "emphasize the long-term character of obesity," comparing it to managing conditions like hypertension.
User Experiences
Users who have discontinued the medication describe a intense return of cravings.
"It was like a switch flipping and you become ravenous," described an individual.
This challenge is worsened if patients have not adopted sustainable lifestyle or habit changes during therapy.
Growing Use
Recent estimates indicate that a significant number of people in the UK have tried these injections in the past year, with demand being substantial.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are effective tools for weight loss, they are not a magic cure and long-term success hinges on combined behavioural management.
